These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 33387511)

  • 1. The genomic landscape of breast cancer brain metastases: a systematic review.
    Morgan AJ; Giannoudis A; Palmieri C
    Lancet Oncol; 2021 Jan; 22(1):e7-e17. PubMed ID: 33387511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated genomic and transcriptomic analysis of human brain metastases identifies alterations of potential clinical significance.
    Saunus JM; Quinn MC; Patch AM; Pearson JV; Bailey PJ; Nones K; McCart Reed AE; Miller D; Wilson PJ; Al-Ejeh F; Mariasegaram M; Lau Q; Withers T; Jeffree RL; Reid LE; Da Silva L; Matsika A; Niland CM; Cummings MC; Bruxner TJ; Christ AN; Harliwong I; Idrisoglu S; Manning S; Nourse C; Nourbakhsh E; Wani S; Anderson MJ; Fink JL; Holmes O; Kazakoff S; Leonard C; Newell F; Taylor D; Waddell N; Wood S; Xu Q; Kassahn KS; Narayanan V; Taib NA; Teo SH; Chow YP; kConFab ; Jat PS; Brandner S; Flanagan AM; Khanna KK; Chenevix-Trench G; Grimmond SM; Simpson PT; Waddell N; Lakhani SR
    J Pathol; 2015 Nov; 237(3):363-78. PubMed ID: 26172396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequent genetic alterations in EGFR- and HER2-driven pathways in breast cancer brain metastases.
    Hohensee I; Lamszus K; Riethdorf S; Meyer-Staeckling S; Glatzel M; Matschke J; Witzel I; Westphal M; Brandt B; Müller V; Pantel K; Wikman H
    Am J Pathol; 2013 Jul; 183(1):83-95. PubMed ID: 23665199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrinsic Subtype Switching and Acquired ERBB2/HER2 Amplifications and Mutations in Breast Cancer Brain Metastases.
    Priedigkeit N; Hartmaier RJ; Chen Y; Vareslija D; Basudan A; Watters RJ; Thomas R; Leone JP; Lucas PC; Bhargava R; Hamilton RL; Chmielecki J; Puhalla SL; Davidson NE; Oesterreich S; Brufsky AM; Young L; Lee AV
    JAMA Oncol; 2017 May; 3(5):666-671. PubMed ID: 27926948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative genomic analysis of primary tumors and metastases in breast cancer.
    Bertucci F; Finetti P; Guille A; Adélaïde J; Garnier S; Carbuccia N; Monneur A; Charafe-Jauffret E; Goncalves A; Viens P; Birnbaum D; Chaffanet M
    Oncotarget; 2016 May; 7(19):27208-19. PubMed ID: 27028851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The repertoire of somatic genetic alterations of acinic cell carcinomas of the breast: an exploratory, hypothesis-generating study.
    Guerini-Rocco E; Hodi Z; Piscuoglio S; Ng CK; Rakha EA; Schultheis AM; Marchiò C; da Cruz Paula A; De Filippo MR; Martelotto LG; De Mattos-Arruda L; Edelweiss M; Jungbluth AA; Fusco N; Norton L; Weigelt B; Ellis IO; Reis-Filho JS
    J Pathol; 2015 Oct; 237(2):166-78. PubMed ID: 26011570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic clonal remodelling in breast cancer metastases is associated with subtype conversion.
    Lluch A; González-Angulo AM; Casadevall D; Eterovic AK; Martínez de Dueñas E; Zheng X; Guerrero-Zotano Á; Liu S; Pérez R; Chen K; Chacón JI; Mills GB; Antolín S; Blancas I; López-Serra P; Carrasco E; Caballero R; Prat A; Rojo F; Gonzalez-Perez A; Meric-Bernstam F; Albanell J
    Eur J Cancer; 2019 Oct; 120():54-64. PubMed ID: 31491604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer brain metastases show increased levels of genomic aberration-based homologous recombination deficiency scores relative to their corresponding primary tumors.
    Diossy M; Reiniger L; Sztupinszki Z; Krzystanek M; Timms KM; Neff C; Solimeno C; Pruss D; Eklund AC; Tóth E; Kiss O; Rusz O; Cserni G; Zombori T; Székely B; Kulka J; Tímár J; Csabai I; Szallasi Z
    Ann Oncol; 2018 Sep; 29(9):1948-1954. PubMed ID: 29917049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive molecular biomarker identification in breast cancer brain metastases.
    Schulten HJ; Bangash M; Karim S; Dallol A; Hussein D; Merdad A; Al-Thoubaity FK; Al-Maghrabi J; Jamal A; Al-Ghamdi F; Choudhry H; Baeesa SS; Chaudhary AG; Al-Qahtani MH
    J Transl Med; 2017 Dec; 15(1):269. PubMed ID: 29287594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein pathway activation mapping of brain metastasis from lung and breast cancers reveals organ type specific drug target activation.
    Improta G; Zupa A; Fillmore H; Deng J; Aieta M; Musto P; Liotta LA; Broaddus W; Petricoin EF; Wulfkuhle JD
    J Proteome Res; 2011 Jul; 10(7):3089-97. PubMed ID: 21574647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic profiling of brain metastases: current knowledge and new frontiers.
    Neagu MR; Gill CM; Batchelor TT; Brastianos PK
    Chin Clin Oncol; 2015 Jun; 4(2):22. PubMed ID: 26112808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the genomic features and expressed fusion genes in micropapillary carcinomas of the breast.
    Natrajan R; Wilkerson PM; Marchiò C; Piscuoglio S; Ng CK; Wai P; Lambros MB; Samartzis EP; Dedes KJ; Frankum J; Bajrami I; Kopec A; Mackay A; A'hern R; Fenwick K; Kozarewa I; Hakas J; Mitsopoulos C; Hardisson D; Lord CJ; Kumar-Sinha C; Ashworth A; Weigelt B; Sapino A; Chinnaiyan AM; Maher CA; Reis-Filho JS
    J Pathol; 2014 Apr; 232(5):553-65. PubMed ID: 24395524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic profiling using the UltraSEEK panel identifies discordancy between paired primary and breast cancer brain metastases and an association with brain metastasis-free survival.
    Giannoudis A; Sartori A; Eastoe L; Zakaria R; Charlton C; Hickson N; Platt-Higgins A; Rudland PS; Irwin D; Jenkinson MD; Palmieri C
    Breast Cancer Res Treat; 2021 Nov; 190(2):241-253. PubMed ID: 34499316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Next generation sequencing of vitreoretinal lymphomas from small-volume intraocular liquid biopsies: new routes to targeted therapies.
    Cani AK; Hovelson DH; Demirci H; Johnson MW; Tomlins SA; Rao RC
    Oncotarget; 2017 Jan; 8(5):7989-7998. PubMed ID: 28002793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A view on the landscape of breast cancer brain metastases.
    Malani R
    CNS Oncol; 2020 Sep; 9(3):CNS59. PubMed ID: 32990026
    [No Abstract]   [Full Text] [Related]  

  • 16. Comprehensive genomic profiling to identify actionable alterations for breast cancer brain metastases in the Chinese population.
    Lu Q; Wang N; Jiang K; Zhou H; Zhang P; Zhang J; Wang S; Sun P; Xu F
    ESMO Open; 2024 Mar; 9(3):102389. PubMed ID: 38460250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic Alterations of Melanoma Brain Metastases: A Systematic Review and Meta-Analysis.
    Pala L; Bagnardi V; Tettamanzi F; Barberis M; Mazzarol G; Casali C; De Pas T; Pennacchioli E; Coppola S; Baldini F; Cocorocchio E; Ferrucci P; Patane' D; Saponara M; Queirolo P; Conforti F
    Mol Diagn Ther; 2023 Jan; 27(1):5-13. PubMed ID: 36401787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ADAM22/LGI1 complex as a new actionable target for breast cancer brain metastasis.
    Charmsaz S; Doherty B; Cocchiglia S; Varešlija D; Marino A; Cosgrove N; Marques R; Priedigkeit N; Purcell S; Bane F; Bolger J; Byrne C; O'Halloran PJ; Brett F; Sheehan K; Brennan K; Hopkins AM; Keelan S; Jagust P; Madden S; Martinelli C; Battaglini M; Oesterreich S; Lee AV; Ciofani G; Hill ADK; Young LS
    BMC Med; 2020 Nov; 18(1):349. PubMed ID: 33208158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of putative actionable alterations in clinically relevant genes in breast cancer.
    Kaur P; Porras TB; Colombo A; Ring A; Lu J; Kang I; Lang JE
    Br J Cancer; 2021 Oct; 125(9):1270-1284. PubMed ID: 34455425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exome sequencing of primary breast cancers with paired metastatic lesions reveals metastasis-enriched mutations in the A-kinase anchoring protein family (AKAPs).
    Kjällquist U; Erlandsson R; Tobin NP; Alkodsi A; Ullah I; Stålhammar G; Karlsson E; Hatschek T; Hartman J; Linnarsson S; Bergh J
    BMC Cancer; 2018 Feb; 18(1):174. PubMed ID: 29433456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.